Detalles de la búsqueda
1.
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
Cancer
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38358334
2.
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
Oncologist
; 29(1): 47-56, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390616
3.
Artificial Intelligence-Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non-Small-Cell Lung Cancer.
Am J Pathol
; 192(4): 701-711, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35339231
4.
A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation.
Transpl Int
; 36: 11552, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37663524
5.
Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.
Oncologist
; 27(7): 525-531, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640145
6.
Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
Oncologist
; 27(6): e471-e483, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348765
7.
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.
Cancer
; 127(17): 3194-3201, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882143
8.
Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC).
Cancer Immunol Immunother
; 70(4): 961-965, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084943
9.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 271-282, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838007
10.
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
Br J Cancer
; 122(3): 340-347, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31761899
11.
Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.
Oncologist
; 24(6): 820-828, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30867242
12.
Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review.
BMC Cancer
; 19(1): 748, 2019 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362708
13.
Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.
Oncologist
; 23(4): 410-421, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29242279
14.
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.
Cancer Immunol Immunother
; 66(1): 25-32, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27761609
15.
Is Personalized Medicine Here?
Oncology (Williston Park)
; 30(4): 293-303, 307, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27085327
16.
Implications of functional proteomics in breast cancer.
Oncologist
; 19(4): 328-35, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24664486
17.
Incidence of immunotherapy-related hyperprogressive disease (HPD) across HPD definitions and cancer types in observational studies: A systematic review and meta-analysis.
Cancer Med
; 13(3): e6970, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400685
18.
Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review.
Front Endocrinol (Lausanne)
; 15: 1304188, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38356955
19.
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
Clin Cancer Res
; 30(1): 33-38, 2024 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882676
20.
Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy.
Clin Lung Cancer
; 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38644088